225Ac-Labeled DOTAylated-huCC49 Antibody

N/A

Report date: 2025/11/07 11:34:03

Base Information

Drug Name225Ac-Labeled DOTAylated-huCC49 Antibody

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Actinium > 225AcRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionTumor-associated glycoprotein 72 binders

TargetsTumor-associated glycoprotein 72

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBeckman Research Institute City Of Hope

China Registration ClassN/A

Develop Information

Active CompaniesBeckman Research Institute City Of Hope

Inactive CompaniesN/A

Active IndicationsOvarian Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A